APSA-IPSO Symposium

Every four years, we partner with the International Society for Paediatric Surgical Oncology (IPSO) to bring you the APSA-IPSO Symposium, where you will learn about the latest trends and advances in pediatric surgical oncology. The Symposium will take place May 13-14, 2020, and is a separate registration from the APSA 2020 Annual Meeting. Both are part of the online and paper registrations.

Register nowRegistration is now available! Take advantage of early bird discounts through March 9, 2020.
Note: IPSO members receive the APSA member price for the APSA 2020 Annual Meeting.

APSA-IPSO Symposium Schedule
Schedule is subject to change, and more details are coming soon.

Wednesday, May 13

8:00 a.m. – 8:15 a.m. Welcome: APSA President and IPSO President 
8:15 a.m. – 10:00 a.m. Scientific Session I: Operative Adjuncts that Improve Cancer Surgery and Reproductive Preservation

Plenary APSA/IPSO Papers
10:00 a.m. – 10:30 a.m.                 Break
10:30 a.m. – Noon                 Seminar Topic I: Care Challenges Facing Low- and Middle- Income Countries
Noon – 1:30 p.m. Lunch (on your own)
1:30 p.m. – 2:30 p.m. Seminar Topic II: Technical Aspects of Rhabdomyosarcoma Surgery
2:30 p.m. – 3:30 p.m. Seminar Topic III: Emerging Technology in Pediatric Cancer Care for the Surgeon
3:30 p.m. – 4:00 p.m. Break
4:00 p.m. – 5:30 p.m. Scientific Session II: Tumor Staging, Sentinel Nodes and PDX Tumor Models
5:30 p.m. – 6:00 p.m.   Free Time
6:00 p.m. – 8:00 p.m. APSA/IPSO Reception

Thursday, May 14

8:00 a.m. – 11:00 a.m. APSA/IPSO Joint Session
Surgeons on the Couch: Wilms Tumor Challenges; Neuroblastoma; Renal


About the International Society of Paediatric Surgical Oncology (IPSO)

The International Society of Paediatric Surgical Oncology (IPSO) is an international society of surgeons who specialize in the surgical care of children with cancer. It is a truly global organization, with expanding membership from around the world, representing 50 different countries. Membership is open to all surgeons who have a demonstrable commitment to pediatric surgical oncology. Learn more.